Home Healthcare Biotechnology Cancer Biomarker Market

Cancer Biomarker Market Size, Share & Trends Analysis Report By Cancer Type (Lung Cancer, Prostate Cancer, Melanoma, Thyroid Cancer, Kidney Cancer, Bladder Cancer, Leukemia, Non-Hodgkin's lymphoma, Colorectal Cancer, Breast Cancer, Other Cancer Types), By Application (Personalized Medicines, Drug Discovery & Development, Diagnostics, Other Applications) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 04, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Cancer Biomarker Market, By Cancer Type 2022-2034 (USD MILLION/ Units)
    1. Lung Cancer
    2. Prostate Cancer
    3. Melanoma
    4. Thyroid Cancer
    5. Kidney Cancer
    6. Bladder Cancer
    7. Leukemia
    8. Non-Hodgkin's lymphoma
    9. Colorectal Cancer
    10. Breast Cancer
    11. Other Cancer Types
  2. Cancer Biomarker Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Personalized Medicines
    2. Drug Discovery & Development
    3. Diagnostics
    4. Other Applications
  3. Regional Cancer Biomarker Market
    1. North America
      1. North America Cancer Biomarker Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
      2. North America Cancer Biomarker Market By Application 2022-2034 (USD MILLION/ Units)
        1. Personalized Medicines
        2. Drug Discovery & Development
        3. Diagnostics
        4. Other Applications
      3. U.S.
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      4. Canada
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
    2. Europe
      1. Europe Cancer Biomarker Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
      2. Europe Cancer Biomarker Market By Application 2022-2034 (USD MILLION/ Units)
        1. Personalized Medicines
        2. Drug Discovery & Development
        3. Diagnostics
        4. Other Applications
      3. U.K.
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      4. Germany
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      5. France
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      6. Spain
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      7. Italy
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      8. Russia
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      9. Nordic
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      10. Benelux
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      11. Rest of Europe
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
    3. APAC
      1. APAC Cancer Biomarker Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
      2. APAC Cancer Biomarker Market By Application 2022-2034 (USD MILLION/ Units)
        1. Personalized Medicines
        2. Drug Discovery & Development
        3. Diagnostics
        4. Other Applications
      3. China
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      4. Korea
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      5. Japan
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      6. India
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      7. Australia
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      8. Singapore
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      9. Taiwan
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      10. South East Asia
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      11. Rest of Asia-Pacific
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
    4. Middle East and Africa
      1. Middle East and Africa Cancer Biomarker Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
      2. Middle East and Africa Cancer Biomarker Market By Application 2022-2034 (USD MILLION/ Units)
        1. Personalized Medicines
        2. Drug Discovery & Development
        3. Diagnostics
        4. Other Applications
      3. UAE
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      4. Turkey
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      5. Saudi Arabia
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      6. South Africa
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      7. Egypt
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      8. Nigeria
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      9. Rest of MEA
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
    5. LATAM
      1. LATAM Cancer Biomarker Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
      2. LATAM Cancer Biomarker Market By Application 2022-2034 (USD MILLION/ Units)
        1. Personalized Medicines
        2. Drug Discovery & Development
        3. Diagnostics
        4. Other Applications
      3. Brazil
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      4. Mexico
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      5. Argentina
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      6. Chile
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      7. Colombia
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
      8. Rest of LATAM
        1. Lung Cancer
        2. Prostate Cancer
        3. Melanoma
        4. Thyroid Cancer
        5. Kidney Cancer
        6. Bladder Cancer
        7. Leukemia
        8. Non-Hodgkin's lymphoma
        9. Colorectal Cancer
        10. Breast Cancer
        11. Other Cancer Types
        12. Personalized Medicines
        13. Drug Discovery & Development
        14. Diagnostics
        15. Other Applications
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.